Vasopressin in Young Patients with Congenital Heart Defects for Postoperative Vasodilatory Shock |
황여주
(가천의대 길병원 심장센터 흉부외과)
안영찬 (가천의대 길병원 심장센터 흉부외) 전양빈 (가천의대 길병원 심장센터 흉부외) 이재웅 (가천의대 길병원 심장센터 흉부외) 박철현 (가천의대 길병원 심장센터 흉부외) 박국양 (가천의대 길병원 심장센터 흉부외) 한미영 (가천의대 길병원 심장센터 소아) 이창하 (가천의대 길병원 심장센터 흉부외과) |
1 |
NG-methyl-Larginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide
/
DOI ScienceOn |
2 |
Vasopressin deficiency contributes to the vasodilation of septic shock
/
DOI ScienceOn |
3 |
Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent
/
DOI ScienceOn |
4 |
Intravenous arginine-vasopressin in children with vasodilatory shock after cardiac surgery
/
|
5 |
Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants: a comparison of low-flow cardiopulmonary bypass and circulatory arrest
/
DOI ScienceOn |
6 |
A prospective randomized trial of arginine vasopress in the treatment of vasodilatory shock after left ventricular assist device placement
/
|
7 |
Treatment of vasodilatory shock after cardiac surgery: low dose arginine vasopressin therapy-three cases report-
/
과학기술학회마을 |
8 |
A doubleblind randomized trial: prophylactic vasopressin reduces hypotension after cardiopulmonary bypass
/
DOI ScienceOn |
9 |
The endocrine system: effects of cardiopulmonary bypass
/
|
10 |
Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock
/
DOI ScienceOn |